INTELLIGENCE IN ACTION

HIMSS19 Showed Glimpses of a Bright Future, But Also Problem Solving in the Here and Now

March 25, 2019

Dr. Andrew Mellin, Surescripts VP of Medical Informatics Physician has been to nearly 20 HIMSS conferences over his career, wearing different hats as a physician, as a vendor and as a health system leader. But this one, his first one as a member of the Surescripts team, felt different, as he explained in a recent article on LinkedIn.

“With my many conversations with provider leaders, technology companies, healthcare associations, and entrepreneurs—I felt like I was at the center of something big and impactful, [as Surescripts] is a facilitator that brings together virtually every major stakeholder in healthcare, including arch competitors, with a common goal to improve safety, lower costs and ensure quality care,” says Dr. Mellin.

“To me, the most profound impact the Surescripts Network Alliance will have in the next few years is removing the opaque reality of an individual person’s financial responsibility for a prescription,” he says.

Dr. Mellin had the opportunity to facilitate a panel at the HIMSS Interoperability Showcase, with a focus on the need for, and transformative power of, prescription price transparency at the point of care. The panelists, all participants in the Network Alliance, talked frankly about the very real need for this technology and that it can be a real game changer in the care journey. Not just for the patient, but for the prescriber, as well, which can help alleviate the very real phenomenon of physician burnout, noted a number of the panelists.

“This HIMSS was different for me—it was not about cool technologies and future promises, but it was about solving difficult, industry-wide problems today. The rapid adoption and value realization for prescription price transparency tools is the manifestation of years of work by my colleagues and people across the industry to build a foundation of trust, technology, and standards,” Dr. Mellin says. “And, I’m excited to work across the industry to put this tool in every provider’s hands and to work with the Surescripts Network Alliance to solve the next hard challenge.”

To read Dr. Mellin’s full take on HIMSS19, check out his article on LinkedIn. And for more on Surescripts’ experience at HIMSS19, be sure to view our highlights video

Related Articles

June 19, 2019

Health Plans and PBMs Team Up to Get Patients Needed Medications Easier and Faster

Anyone who works in health IT knows how gratifying it is when we offer clinicians a tool that is so much better than old processes, and they run with it. And it’s especially transformative when technology replaces a manual process—one that absorbed a great deal of time and resources.  Read more...
May 21, 2019

An Urgent Call for Transformation: Prescribers Need Better Information and a Streamlined Specialty Prescribing Process

Most likely, you or someone you love has been impacted by a complex or chronic illness like cancer or multiple sclerosis. Sadly, these diseases—and the cost of medications to treat them—are on the rise. More than half of specialty drugs cost in excess of $100,000 a year. As a result, spending on branded specialty medications is rising by 10 percent a year and is projected to surpass half of all medication spending by 2022, even though these drugs comprise just a fraction of all prescribed medications.

Read more...
May 20, 2019

Federal Government Issues Final Rule: Part D Plans Must Adopt a Real Time Benefit Tool

On May 16, the Centers for Medicare and Medicaid Services (CMS) issued its final rule: Medicare Advantage and Part D Drug Pricing Final Rule (CMS-4180-F).

We’ve been closely following this proposal as it relates to e-prescribing and the Part D prescription drug plan in particular. The rule is designed to accelerate the use of Real Time Benefit Tools (RTBTs), such as Surescripts Real-Time Prescription Benefit.

Read more...

INTELLIGENCE IN ACTION, DELIVERED TO YOUR INBOX